Indicellbio India Private Limited
About Indicellbio India Private Limited
Data last updated:
Indicellbio India Private Limited is a foreign private limited company based in Chennai, Tamil Nadu, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 07 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24299TN2021FTC148433.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amita Balwant Shirke and Jong Soo Lee.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.28 2nd Floor S1 Sekaran'S Apt Sri Sairam Nagar Perumbakkam, Chennai, Tamil Nadu, India – 600100.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.94 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9.18 Lakh (net margin -76.9%) and EBITDA of -₹9.15 Lakh (EBITDA margin -76.6%).
Company details
Contact details
Indicellbio India Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo.28 2nd Floor S1 Sekaran'S Apt Sri Sairam Nagar Perumbakkam, Chennai, Tamil Nadu, India – 600100
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indicellbio India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indicellbio India Private Limited, buy the company report.
Financials of Indicellbio India Private Limited
FY 2025 filings availableIndicellbio India Private Limited reported revenue of ₹11.94 Lakh (up 298% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 298% in the latest year. EBITDA rose 47% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹9.15 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹9.18 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -76.6% | ||
| Net Profit Margin | -76.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Indicellbio India Private Limited, buy the company report.
Board of directors of Indicellbio India Private Limited
Indicellbio India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amita Balwant Shirke | Director | 07 Dec 2021 | 4 Years 11 Months | Current |
| Jong Soo Lee | Director | 16 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Indicellbio India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Blimet Pharma Private Limited | ₹11.95 Lakh (FY 2021) | 375.0% | Aurangabad, Maharashtra, India | |||
| Chamunda Enterprises Private Limited | ₹11.95 Lakh (FY 2017) | -58.0% | New Delhi, Delhi, India | |||
| SSJ Enterprises Private Limited | ₹11.94 Lakh (FY 2024) | -59.0% | Nizampet, Telangana, India | |||
| Dadimata Dealers Private Limited | ₹11.94 Lakh (FY 2025) | 37.0% | Kolkata, West Bengal, India | |||
| Ayush Power Electricals India Private Limited | ₹11.94 Lakh (FY 2021) | Indore, Madhya Pradesh, India | ||||
| Indicellbio India Private Limitedthis company | ₹11.94 Lakh (FY 2024) | -₹9.18 Lakh | -76.9% | 298.0% | Chennai, Tamil Nadu, India | |
| Lords Overseas Ltd | ₹11.94 Lakh (FY 2024) | -41.0% | Kolkata, West Bengal, India | |||
| Excelsafepower India Private Limited | ₹11.94 Lakh (FY 2024) | -15.0% | Thrissur, Kerala, India | |||
| Zahracure Exim Private Limited | ₹11.94 Lakh (FY 2025) | -94.0% | Ahmedabad, Gujarat, India | |||
| V Talk India Private Limited | ₹11.94 Lakh (FY 2022) | 7.0% | Delhi, India | |||
| BKJD Millets and Food Products Private Limited | ₹11.94 Lakh (FY 2023) | Nashik, Maharashtra, India |
To see the full peer comparison of Indicellbio India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indicellbio India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indicellbio India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Indicellbio India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Indicellbio India Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Jong Park Young ceased to be Director on 16 Sep 2024.
Frequently asked questions
Indicellbio India is an active foreign private limited company based in Chennai, Tamil Nadu, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 07 December 2021 (5+ years old) and is registered under CIN U24299TN2021FTC148433.
Indicellbio India has 2 current directors:
- Amita Balwant Shirke - Director
- Jong Soo Lee - Director
The latest financial statements of Indicellbio India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Indicellbio India is U24299TN2021FTC148433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indicellbio India was incorporated on 07 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Indicellbio India by revenue are Blimet Pharma Private Limited, Chamunda Enterprises Private Limited, SSJ Enterprises Private Limited, Dadimata Dealers Private Limited, Ayush Power Electricals India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Jong Park Young ceased to be Director on 16 Sep 2024. Jong Soo Lee was appointed as Director on 16 Sep 2024. Amita Balwant Shirke was appointed as Director on 07 Dec 2021. Indicellbio India has 4 board changes on record in total.
The registered office of Indicellbio India is at No.28 2nd Floor S1 SekaranS Apt Sri Sairam Nagar Perumbakkam, Chennai, Tamil Nadu, India – 600100.
Indicellbio India operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Indicellbio India can be reached at its registered office: No.28 2nd Floor S1 SekaranS Apt Sri Sairam Nagar Perumbakkam, Chennai, Tamil Nadu, India – 600100.
Indicellbio India is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
